MedPath

Online Spaced Education to Improve Fall Prevention by Patients With Multiple Sclerosis

Not Applicable
Conditions
Education of Patients
Interventions
Other: Brochure Education
Other: Online Spaced Education
Registration Number
NCT03737097
Lead Sponsor
Hospital Israelita Albert Einstein
Brief Summary

Multiple sclerosis (MS) is a chronic, progressive and neurodegenerative inflammatory disease that affects young adults. In many countries it has been described as the main cause of neurological incapacity in this age group. Due to the neurological impairment, patients with multiple sclerosis have a high incidence of fall. According to studies, MS patients fall three times more than general population. In the present study, the question to be answered is: education of individuals with MS on fall prevention using the method of online spaced education provides better retention of knowledge than the traditional method? This is a clinical trial to compare two methods of education of MS patients for prevention of fall. First stage: Development and validation of materials. Step two: Pilot questions with MS patients. Step three: Intervention and evaluation of outcome.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
320
Inclusion Criteria
  • Multiple sclerosis diagnosis
  • Accept to be part in the study
  • Have valid e-mail address
Exclusion Criteria
  • Healthcare professionals;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Brochure EducationBrochure EducationThe control cohort will receive the fall prevention education in bolus through a Brochure developed by the National Multiple Sclerosis Society. The brochure was translated to portuguese and will be used in the study with authorization of the Society.
Online Spaced EducationOnline Spaced EducationThe intervention cohort will participate in an online spaced education on fall prevention education developed for patients with multiple sclerosis.
Primary Outcome Measures
NameTimeMethod
Change in test scores between cohorts measured in weeks 1-24Months 1-6

Test scores on fall prevention strategies tests in both cohorts will be registered and compared in weeks 1, 12 and 24

Secondary Outcome Measures
NameTimeMethod
Fall rateMonths 1-6

Number of self-reported falls registered by the patients in both cohorts will be compared in weeks 1, 12 and 24

Adherence to fall prevention strategiesMonths 1-6

The study will apply the Falls Prevention Strategies Survey in both cohorts in weeks 1, 12 and 24. It is a self-report instrument addressing protective behaviors related to fall risk among adults with multiple sclerosis (MS) (eg, monitoring MS symptoms, wearing proper footwear, modifying activities). Response options reflect the frequency with which the respondent engages in the behavior (ie, never, sometimes, regularly)

Individuals satisfaction with the fall prevention education methodMonths 3-6

Individuals will be asked to evaluate their satisfaction with the method they were signed in the study by a five-point Likert scale (very dissatisfied, dissatisfied, neutral, satisfied, very satisfied). Answers will be compared between both cohorts in weeks 12 and 24.

Baseline knowledge levels of patients assessed via their initial responses to the questionsMonth 1

Previous knowledge about fall prevention strategies will be evaluated in week 1 in both cohorts and compared

Pre and post-test performances differences by history of fallsMonths 1-6

Patient performance in pre and post-tests will be evaluated in both cohorts and will be compared between fallers and non-fallers in the group and between the cohorts in weeks 1, 12 and 24. We will consider fallers the individuals, in both groups, that have at least one reported fall in the past six months in the enrollment in the study.

Pre and post-test performances differences by ageMonth 1-6

Patient performance will be evaluated in both cohorts and compared by age in weeks 1, 12 and 24

Pre and post-test performances differences by genderMonth 1-6

Patient performance will be evaluated in both cohorts and compared by gender in weeks 1, 12 and 24

Trial Locations

Locations (1)

Sociedade Benef Israelitabras Hospital Albert Einstein

🇧🇷

São Paulo, Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath